ICON Eyecare participates in several national clinical research trials in an effort to enrich and develop better treatment options for our patients for a variety of medical ophthalmic conditions and diseases including glaucoma, dry eye, and cataracts.
If you are interested in learning more or participating in any of our ongoing clinical research trials, please contact Chris Bosch, Clinical Research Coordinator at 970.205.9555 or Chris.Bosch@iconeyecare.com.
‘Oasis’ by Allysta Pharmaceuticals, Inc. – For adults with dry eye symptoms
‘Sahara’ by Sight Sciences, Inc. – For adults 22+ with dry eye symptoms
‘Argos’ by Allergan – For adults with glaucoma
‘Elios’ by Elios Vision, Inc. – For adults 45+ with glaucoma AND cataracts
‘Melt-300’ by Melt Pharmaceuticals, Inc. – For adults 55-80 with cataracts
‘Esther’ by Théa Laboratories – For adults with glaucoma
‘VVN539’ by VivaVision Biotech, Inc. – For adults with glaucoma
‘K-321’ by Kowa Research Institute, Inc. – For adults with cataracts